1. In this retrospective cohort of individuals with dementia, there was no statistically significant difference between donepezil or memantine compared ...
Patients with wet age-related macular degeneration receiving CLS-AX achieved stable visual acuity, and retinal thickness for up to six months. ...
1. Fewer anti-VEGF intravitreal injections were required in the SRT group over 2 years. 2. Change in visual acuity was ...
Click here to read this study in JAMA Ophthalmology. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. Aflibercept 8 mg was non-inferior to 2 mg for best-corrected visual acuity at 48 weeks. 2. Ocular adverse events ...
1. Avacincaptad pegol significantly slowed geographic atrophy over 12 months. 2. Exudative macular neovascularization was comparable among treatment groups. Evidence ...
1. In a phase 3a randomized trial comparing intravitreal brolucizumab to aflibercept for refractory neovascular age-related macular degeneration (nAMD), there ...
1. In both trials, faricimab was demonstrated to be non-inferior to aflibercept at improving visual acuity in neovascular age-related macular ...
1. The findings demonstrated non-superiority of using a combination of prednisolone and nonsteroidal anti-inflammatory drug eye drops compared to nonsteroidal ...
Originally published by Harvard Health. What Is It? Macular degeneration is a common cause of blindness and vision problems among older ...
